• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Illumina

Illumina

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  1. ILMN SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of a Class Action Involving Illumina , Inc. and a Lead Plaintiff Deadline of February 14, 2017

    ILMN SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of a Class Action Involving Illumina , Inc. and a Lead Plaintiff Deadline of February 14, 2017

  2. Illumina to Announce Fourth Quarter and Fiscal Year 2016 Financial Results on Tuesday, January 31, 2017

    Illumina to Announce Fourth Quarter and Fiscal Year 2016 Financial Results on Tuesday, January 31, 2017

  3. ILMN LOSS NOTICE: Rosen Law Firm Reminds Illumina , Inc. Investors of Important Deadline in Class Action – ILMN

    ILMN LOSS NOTICE: Rosen Law Firm Reminds Illumina , Inc. Investors of Important Deadline in Class Action – ILMN

  4. Illumina and Bio-Rad Launch Solution for Single-Cell Genomic Sequencing to Enable Robust Study of Complex Diseases

    Illumina and Bio-Rad Launch Solution for Single-Cell Genomic Sequencing to Enable Robust Study of Complex Diseases

  5. MARKET SNAPSHOT: Dow Takes Another Run At 20,000 As Nasdaq Aims For 3rd Straight Record

    MARKET SNAPSHOT: Dow Takes Another Run At 20,000 As Nasdaq Aims For 3rd Straight Record

  6. UPDATE: Dow takes another run at 20,000 as Nasdaq aims for 3rd straight record

    UPDATE: Dow takes another run at 20,000 as Nasdaq aims for 3rd straight record

  7. UPDATE: These are the 10 best and 10 worst U.S. stocks of 2017

    UPDATE: These are the 10 best and 10 worst U.S. stocks of 2017

  8. UPDATE: These are the 10 best and 10 worst U.S. stocks of 2017

    UPDATE: These are the 10 best and 10 worst U.S. stocks of 2017

  9. UPDATE: These are the 10 best and 10 worst U.S. stocks of 2017

    UPDATE: These are the 10 best and 10 worst U.S. stocks of 2017

  10. $8.78 Billion Microfluidics Market 2016-2021: Focus on Genomics, Proteomics, Capillary Electrophoresis, POC, Clinical, Environmental & Drug Delivery - Research and Markets

    $8.78 Billion Microfluidics Market 2016-2021: Focus on Genomics, Proteomics, Capillary Electrophoresis, POC, Clinical, Environmental & Drug Delivery - Research and Markets

12
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.